← Leaderboards
Jayashri Ghosh
Temple Univ Of The Commonwealth
$1,502,807
Attributed
$1,704,726
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $525.6K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,704,726 · 2
By mechanism
R01$1,300,887 · 1
R21$403,839 · 1
Top collaborators
- Carmen Sapienza2 shared
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsPhenotypeEpigenetic ProcessIncidenceMortalityNormal Tissue MorphologyDietEnvironmental Risk FactorEpigenomeGeneticColon Cancer PatientsMethylationMucous MembraneColonoscopyAffectBloodBlood SpecimenDna MethylationCaucasiansColonFrequenciesCancer PatientAfrican AmericanPolyps
Grant awards (5)
Development of blood-based methylation biomarkers for CRC risk prediction$384,608
R01 · FY2025 · CA · contact PI
Development of blood-based methylation biomarkers for CRC risk prediction$525,618
R01 · FY2024 · CA · contact PI
Development of blood-based methylation biomarkers for CRC risk prediction$390,661
R01 · FY2023 · CA · contact PI
Are racial disparities in colon cancer due to epigenetic outliers.$181,543
R21 · FY2022 · CA
Are racial disparities in colon cancer due to epigenetic outliers.$222,296
R21 · FY2021 · CA